B-Cancer	0	10	Neoplastic	Neoplastic	JJ	B-NP
O	11	25	transformation	transformation	NN	I-NP
O	26	29	and	and	CC	I-NP
O	30	43	tumorigenesis	tumorigenesis	NN	I-NP
O	44	54	associated	associate	VBN	B-VP
O	55	59	with	with	IN	B-PP
O	60	74	overexpression	overexpression	NN	B-NP
O	75	77	of	of	IN	B-PP
O	78	91	phospholipase	phospholipase	NN	B-NP
O	92	93	D	D	NN	I-NP
O	94	102	isozymes	isozyme	NNS	I-NP
O	103	105	in	in	IN	B-PP
O	106	114	cultured	culture	VBN	B-NP
O	115	121	murine	murine	JJ	I-NP
B-Cell	122	133	fibroblasts	fibroblast	NNS	I-NP
O	133	134	.	.	.	O

O	136	149	Phospholipase	Phospholipase	NN	B-NP
O	150	151	D	D	NN	I-NP
O	152	153	(	(	(	O
O	153	156	PLD	PLD	NN	B-NP
O	156	157	)	)	)	O
O	158	161	has	have	VBZ	B-VP
O	162	166	been	be	VBN	I-VP
O	167	176	suggested	suggest	VBN	I-VP
O	177	179	to	to	TO	B-VP
O	180	184	play	play	VB	I-VP
O	185	187	an	an	DT	B-NP
O	188	197	important	important	JJ	I-NP
O	198	202	role	role	NN	I-NP
O	203	205	in	in	IN	B-PP
O	206	207	a	a	DT	B-NP
O	208	215	variety	variety	NN	I-NP
O	216	218	of	of	IN	B-PP
B-Cell	219	227	cellular	cellular	JJ	B-NP
O	228	237	functions	function	NNS	I-NP
O	237	238	.	.	.	O

O	239	242	PLD	PLD	NN	B-NP
O	243	251	activity	activity	NN	I-NP
O	252	255	has	have	VBZ	B-VP
O	256	260	been	be	VBN	I-VP
O	261	266	shown	show	VBN	I-VP
O	267	269	to	to	TO	I-VP
O	270	272	be	be	VB	I-VP
O	273	286	significantly	significantly	RB	B-ADJP
O	287	295	elevated	elevated	JJ	I-ADJP
O	296	298	in	in	IN	B-PP
O	299	303	many	many	JJ	B-NP
B-Cancer	304	311	tumours	tumour	NNS	I-NP
O	312	315	and	and	CC	O
O	316	327	transformed	transform	VBN	B-VP
B-Cell	328	333	cells	cell	NNS	B-NP
O	333	334	,	,	,	O
O	335	345	suggesting	suggest	VBG	B-VP
O	346	349	the	the	DT	B-NP
O	350	361	possibility	possibility	NN	I-NP
O	362	366	that	that	IN	B-SBAR
O	367	370	PLD	PLD	NN	B-NP
O	371	376	might	might	MD	B-VP
O	377	379	be	be	VB	I-VP
O	380	388	involved	involve	VBN	I-VP
O	389	391	in	in	IN	B-PP
O	392	405	tumorigenesis	tumorigenesis	NN	B-NP
O	405	406	.	.	.	O

O	407	409	In	In	IN	B-PP
O	410	414	this	this	DT	B-NP
O	415	420	study	study	NN	I-NP
O	420	421	,	,	,	O
O	422	424	we	we	PRP	B-NP
O	425	429	have	have	VBP	B-VP
O	430	441	established	establish	VBN	I-VP
O	442	448	stable	stable	JJ	B-NP
B-Cell	449	453	cell	cell	NN	I-NP
I-Cell	454	459	lines	line	NNS	I-NP
O	460	474	overexpressing	overexpresse	VBG	B-VP
O	475	479	PLD1	PLD1	NN	B-NP
O	480	483	and	and	CC	I-NP
O	484	488	PLD2	PLD2	NN	I-NP
O	489	493	from	from	IN	B-PP
B-Cell	494	504	fibroblast	fibroblast	NN	B-NP
I-Cell	505	510	cells	cell	NNS	I-NP
O	510	511	.	.	.	O

O	512	517	These	These	DT	B-NP
B-Cell	518	523	cells	cell	NNS	I-NP
O	523	524	,	,	,	O
O	525	528	but	but	CC	O
O	529	532	not	not	RB	O
O	533	540	control	control	NN	B-NP
B-Cell	541	546	cells	cell	NNS	I-NP
O	546	547	,	,	,	O
O	548	554	showed	show	VBD	B-VP
O	555	562	altered	alter	VBN	B-NP
O	563	569	growth	growth	NN	I-NP
O	570	580	properties	property	NNS	I-NP
O	581	584	and	and	CC	O
O	585	594	anchorage	anchorage	NN	B-NP
O	594	595	-	-	HYPH	I-NP
O	595	606	independent	independent	JJ	I-NP
O	607	613	growth	growth	NN	I-NP
O	614	616	in	in	IN	B-PP
O	617	621	soft	soft	JJ	B-NP
O	622	626	agar	agar	NN	I-NP
O	626	627	.	.	.	O

O	628	632	Both	Both	CC	O
O	633	637	PLD1	PLD1	NN	B-NP
O	638	641	and	and	CC	I-NP
O	642	646	PLD2	PLD2	NN	I-NP
O	647	651	also	also	RB	B-ADVP
O	652	659	induced	induce	VBD	B-VP
O	660	662	an	an	DT	B-NP
O	663	665	up	up	RB	I-NP
O	665	666	-	-	HYPH	I-NP
O	666	676	regulation	regulation	NN	I-NP
O	677	679	of	of	IN	B-PP
O	680	683	the	the	DT	B-NP
O	684	692	activity	activity	NN	I-NP
O	693	695	of	of	IN	B-PP
O	696	702	matrix	matrix	NN	B-NP
O	703	718	metalloprotease	metalloprotease	NN	I-NP
O	718	719	-	-	HYPH	O
O	719	720	9	9	CD	B-NP
O	721	723	as	as	IN	B-SBAR
O	724	732	detected	detect	VBN	B-VP
O	733	735	by	by	IN	B-PP
O	736	745	zymograms	zymogram	NNS	B-NP
O	745	746	.	.	.	O

O	747	758	Furthermore	Furthermore	RB	B-ADVP
O	758	759	,	,	,	O
O	760	764	both	both	CC	O
B-Cell	765	769	PLD1	PLD1	NN	B-NP
O	770	773	and	and	CC	I-NP
B-Cell	774	778	PLD2	PLD2	NN	I-NP
I-Cell	779	792	transformants	transformant	NNS	I-NP
O	792	793	,	,	,	O
O	794	797	but	but	CC	O
O	798	801	not	not	RB	O
B-Cell	802	808	vector	vector	NN	B-NP
I-Cell	808	809	-	-	HYPH	B-NP
I-Cell	809	822	transfectants	transfectant	NNS	I-NP
O	822	823	,	,	,	O
O	824	831	induced	induce	VBD	B-VP
O	832	848	undifferentiated	undifferentiated	JJ	B-NP
B-Cancer	849	856	sarcoma	sarcoma	NN	I-NP
O	857	861	when	when	WRB	B-ADVP
O	862	874	transplanted	transplant	VBN	B-VP
O	875	879	into	into	IN	B-PP
O	880	884	nude	nude	JJ	B-NP
O	885	889	mice	mouse	NNS	I-NP
O	889	890	.	.	.	O

O	891	895	Both	Both	CC	O
O	896	900	PLD1	PLD1	NN	B-NP
O	900	901	-	-	HYPH	B-NP
O	902	905	and	and	CC	I-NP
O	906	910	PLD2	PLD2	NN	I-NP
O	910	911	-	-	HYPH	O
O	911	919	mediated	mediate	VBN	B-NP
B-Cell	920	924	cell	cell	NN	I-NP
O	925	930	cycle	cycle	NN	I-NP
O	931	944	distributions	distribution	NNS	I-NP
O	945	947	in	in	IN	B-PP
O	948	954	stable	stable	JJ	B-NP
B-Cell	955	959	cell	cell	NN	I-NP
I-Cell	960	965	lines	line	NNS	I-NP
O	966	974	revealed	reveal	VBD	B-VP
O	975	977	an	an	DT	B-NP
O	978	987	increased	increase	VBN	I-NP
O	988	996	fraction	fraction	NN	I-NP
O	997	999	of	of	IN	B-PP
B-Cell	1000	1005	cells	cell	NNS	B-NP
O	1006	1008	in	in	IN	B-PP
O	1009	1012	the	the	DT	B-NP
O	1013	1014	S	S	NN	I-NP
O	1015	1020	phase	phase	NN	I-NP
O	1021	1029	compared	compare	VBN	B-PP
O	1030	1034	with	with	IN	B-PP
O	1035	1042	control	control	NN	B-NP
B-Cell	1043	1048	cells	cell	NNS	I-NP
O	1048	1049	.	.	.	O

O	1050	1063	Interestingly	Interestingly	RB	B-ADVP
O	1063	1064	,	,	,	O
O	1065	1068	the	the	DT	B-NP
O	1069	1074	level	level	NN	I-NP
O	1075	1077	of	of	IN	B-PP
O	1078	1084	cyclin	cyclin	NN	B-NP
O	1085	1087	D3	D3	NN	I-NP
O	1088	1095	protein	protein	NN	I-NP
O	1095	1096	,	,	,	O
O	1097	1102	known	know	VBN	B-VP
O	1103	1105	as	as	IN	B-PP
O	1106	1108	an	an	DT	B-NP
O	1109	1118	activator	activator	NN	I-NP
O	1119	1121	of	of	IN	B-PP
O	1122	1123	G	G	NN	B-NP
O	1123	1124	(	(	(	O
O	1124	1125	1	1	CD	B-NP
O	1125	1126	)	)	)	O
O	1127	1129	to	to	TO	B-PP
O	1130	1131	S	S	NN	B-NP
O	1132	1137	phase	phase	NN	I-NP
O	1138	1148	transition	transition	NN	I-NP
O	1149	1151	in	in	IN	B-PP
O	1152	1155	the	the	DT	B-NP
B-Cell	1156	1160	cell	cell	NN	I-NP
O	1161	1166	cycle	cycle	NN	I-NP
O	1166	1167	,	,	,	O
O	1168	1171	was	be	VBD	B-VP
O	1172	1182	aberrantly	aberrantly	RB	B-ADJP
O	1183	1187	high	high	JJ	I-ADJP
O	1188	1190	in	in	IN	B-PP
B-Cell	1191	1196	cells	cell	NNS	B-NP
O	1197	1211	overexpressing	overexpresse	VBG	B-VP
O	1212	1216	PLD1	PLD1	NN	B-NP
O	1217	1220	and	and	CC	I-NP
O	1221	1225	PLD2	PLD2	NN	I-NP
O	1226	1234	compared	compare	VBN	B-PP
O	1235	1239	with	with	IN	B-PP
O	1240	1247	control	control	NN	B-NP
B-Cell	1248	1253	cells	cell	NNS	I-NP
O	1253	1254	.	.	.	O

O	1255	1260	These	These	DT	B-NP
O	1261	1268	results	result	NNS	I-NP
O	1269	1276	suggest	suggest	VBP	B-VP
O	1277	1281	that	that	IN	B-SBAR
O	1282	1296	overexpression	overexpression	NN	B-NP
O	1297	1299	of	of	IN	B-PP
O	1300	1303	PLD	PLD	NN	B-NP
O	1304	1312	isozymes	isozyme	NNS	I-NP
O	1313	1316	may	may	MD	B-VP
O	1317	1321	play	play	VB	I-VP
O	1322	1324	an	an	DT	B-NP
O	1325	1334	important	important	JJ	I-NP
O	1335	1339	role	role	NN	I-NP
O	1340	1342	in	in	IN	B-PP
B-Cancer	1343	1353	neoplastic	neoplastic	JJ	B-NP
O	1354	1368	transformation	transformation	NN	I-NP
O	1368	1369	.	.	.	O

